QuVa Pharma Revenue and Competitors

Houston, TX USA

Location

$356M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • QuVa Pharma's estimated annual revenue is currently $264M per year.(i)
  • QuVa Pharma received $41.0M in venture funding in July 2018.
  • QuVa Pharma's estimated revenue per employee is $321,600
  • QuVa Pharma's total funding is $356M.

Employee Data

  • QuVa Pharma has 821 Employees.(i)
  • QuVa Pharma grew their employee count by 1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$107.3M5349%N/AN/A
#2
$97.9M252-7%N/AN/A
Add Company

QuVa Pharma is a nationally recognized company emerging as the leading industry 503B platform and partner of choice for compliance-oriented healthcare facilities looking to ensure a quality, safe and consistent supply of medications. The Company offers a broad portfolio of products across Pain Management, Anti-infective, OR Syringes, Labor and Delivery therapeutic areas amongst others, all of which are released only once sterility and potency testing is successfully complete, and with validation supporting appropriate BUD. The company is committed to having a patient-first orientation, as well as a robust product portfolio, leading safety standards, and collaborative, partnership-oriented customer service.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$356M

Total Funding

821

Number of Employees

$264M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

QuVa Pharma's People

NameTitleEmail/Phone
1
Customer Integration SpecialistReveal Email/Phone
2
Technical Support SpecialistReveal Email/Phone
3
Quality System Lead - CorporateReveal Email/Phone
4
Director National AccountsReveal Email/Phone
5
Hospital Account ManagerReveal Email/Phone
6
Plant ControllerReveal Email/Phone
7
Purchasing ManagerReveal Email/Phone
8
Lead Quality Assurance SpecialistReveal Email/Phone
9
National Account DirectorReveal Email/Phone
10
Director, Learning and DevelopmentReveal Email/Phone

QuVa Pharma News

2022-04-13 - US Injectable Compounding Pharmacy Market Size Worth ...

On April 28, 2020, QuVa Pharma Inc., a U.S. based intensifying drug ... market include Atlas Pharmaceuticals, Avella Specialty Pharmacy,...

2021-05-06 - QuVa Pharma Completes $275 Million Financing with Syndicate Led by Goldman Sachs

SUGAR LAND, Texas, May 6, 2021 /PRNewswire/ -- QuVa Pharma, Inc.("QuVa Pharma"), the leading national 503B outsourcing services company providing hospitals with essential medications in ready-to-administer injectable formats, today announced its latest financing, a $275 million senior debt fac ...

2020-10-28 - QuVa Pharma Expands Its Partnership With Kit Check™ to Help Hospitals Improve Medication Management and Automation Through RFID Tagging

SUGAR LAND, Texas, Oct. 28, 2020 /PRNewswire/ -- QuVa Pharma, Inc. announces it has expanded its partnership with Kit Check to support its increasing portfolio of products that include embedded RFID tags. The embedded RFID tags allow hospital pharmacists to add batches of medications to invent ...

2018-09-26 - QuVa Pharma Announces Significant New Production ...

SUGAR LAND, Texas, Sept. 26, 2018 /PRNewswire/ -- QuVa Pharma, Inc. today announced it has commenced manufacturing in newly ...

2018-07-25 - QuVa Pharma Raises Up To $41M Debt Funding

QuVa Pharma, a Sugar Land, Texas-based provider of compounded sterile products, raised additional debt funding of up to $41m. The new term loan is funded jointly by Silicon Valley Bank and Oxford Finance LLC. This additional capital infusion, which brings total capital invested to over $200 mil ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$307.3M8964%N/A
#2
$410M9016%N/A
#3
$6250M9101%$11M
#4
$323.1M942-2%N/A
#5
$410.5M10868%N/A

QuVa Pharma Funding

DateAmountRoundLead InvestorsReference
2018-02-01$15.0MUndisclosedBain CapitalArticle
2018-07-25$41.0MUndisclosedSilicon Valley BankArticle